5-Benzyl-7-(hydroxyimino)-5-azaspiro[2.4]heptan-4-one, 98%, 100mg

3-Methyloctane>99.0%(GC)5mL

2-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid, 97%, 5g

4-Chloro-7-methyl-1H-pyrazolo[4,3-c]pyridine, 98+%, 500mg

2-(Methylsulfonyl)ethanamine, 97.0%, 100mg

2,4-Dihydroxybenzaldéhyde, min 98 %, pour la synthèse, 100 g, emballage en verre

ethyl 5-chloro-2-fluorobenzoate, 1g

2-Phenyl-5-trifluoromethyl-2H-pyrazol-3-ol, 95.0%, 1g

1-(tert-Butyl) 2-methyl (2S,4S)-4-(hydroxymethyl)pyrrolidine-1,2-dicarboxylate, 98%, 100mg

4-Chloro-5,6-dimethylthieno[2,3-d]pyrimidine, 96.0%, 100mg

5-(Benzyloxy)-2-chloropyridine, 97%, 500mg

2-Amino-3-methoxybenzoic Acid>99.0%(HPLC)(T)5g

1,2,3-Cyclohexanetriol (cis- and trans- mixture)>97.0%(GC)10g